METABOLIC CHANGES ASSOCIATED WITH METFORMIN POTENTIATES ANTI-BCL-2 INHIBITOR, ABT-199, AND CDK9 INHIBITOR, BAY-1143572 AND REDUCES VIABILITY OF LYMPHOMA CELLS
Karmali, R., Chukkapalli, V., Gordon, L.I., Borgia, J.A.Volume:
35
Language:
english
Journal:
Hematological Oncology
DOI:
10.1002/hon.2439_176
Date:
June, 2017
File:
PDF, 186 KB
english, 2017